In this same study, melatonin upregulated CES1 expression, which decreased lipid accumulation and cell activity by prostate cancer cells, as well as inhibited castrate-resistant prostate cancer progression, and reversed enzalutamide progression.69 Here, CES1 is linked to prostate carcinoma.